Kenya’s vaccine manufacturing plant to cost taxpayers Sh2 billion
National
By
Rosa Agutu
| Oct 22, 2021
The vaccine manufacturing company announced by President Uhuru Kenyatta during the Mashujaa Day celebrations, will cost taxpayers Sh2 billion.
The company named Kenya Biovax Limited in Nairobi’s Embakasi area, will start operations in the next six months as “fill and finish” plant under the Ministry of Health.
Health CS Mutahi Kagwe said during a Presser to clarify on curfew hours that a multi-agency technical team has been working on the project and the Sh2 billion will be used in buying equipment to ensure Kenya, which has been relying on dose donations during the Covid-19 pandemic, is self-reliant
READ MORE
Is government on 'fuliza' mode? What Treasury numbers show
Expert: The shilling has regained value, but don't expect it to last
EAC Central Bank Governors meet in Juba as single currency race debate heats up
Ruto to push for global finance reforms at World Bank meeting
Unearthing the artifacts of WWII: A journey through Matuu and beyond
Roam, County Bus Service partner to deploy 200 electric buses
Budget cuts loom for Parliament thanks to Sh9.6b Bunge Towers
Private sector partnerships important to catalysing sports
Tax stand-off as boda boda riders defy county call to pay
Islamic banking gets traction in Africa as Salaam Bank feted
“Given the experience we have had in last one year and the danger of dependency on other countries for vaccines it’s pretty obvious that this is an investment that should have been made a long time ago,” said Kagwe.
“We make animal vaccines but why we don’t human vaccines is a strange phenomenon.”
On how the ministry will ensure the pastoralists community are vaccinated Kagwe said that the counties are in charge of on how their people are vaccinated besides the ministry partnering with Red Cross and AMREF to ensure pastoralists have access to vaccines.
The Acting Director General for Health, Dr Patrick Amoth added that the Ministry of Health was working with World Food Programme and the Ministry of ASAL to ensure vaccinations are also carried out during supply of relief food.
Dr Amoth warned that the Delta variant is still the dominant variant but has “a sub variant…that might disrupt our vaccination programme.”
- Is government on 'fuliza' mode? What Treasury numbers show
- Manufacturers struggle under high taxation and energy costs